BridgeMD
Tests treatment safety and results for Locally Advanced Breast Cancer
Official title The Choice of Treatment Methods and Efficacy of LABC
ClinicalTrials.gov ID: NCT06080620
What this study is testing
- What it's testing
- The goal of this clinical trial is to compare the therapeutic effects of chemotherapy followed by surgery and surgery followed by chemotherapy in patients with locally advanced breast cancer（LABC). Patients with LABC will be randomly divided into two groups, each receiving chemotherapy followed by surgery or surgery followed by chemotherapy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70, women only
You may be able to join if
- 18-70 year old female
- Patients with locally advanced breast cancer (stage IIIb - IIIc) first diagnosed;
- Clinical diagnosis of breast cancer, or puncture pathology suggests breast cancer;
- After evaluation by experienced clinical physicians, the patient's tumor has the possibility of surgical resection. Specific evaluation indicators...
- Accept treatment plans including surgery, radiotherapy, and chemotherapy;
You likely can't join if
- Patients under 18 years old or over 70 years old;
- Those who have received breast cancer related surgery, radiotherapy or chemotherapy;
- Those who are not expected to receive surgery, radiotherapy or chemotherapy related to breast cancer
- History of other malignant tumors;
- Pregnant or lactating women;
- Accompanying active infection and fever;
See the full eligibility criteria
- 18-70 year old female
- Patients with locally advanced breast cancer (stage IIIb - IIIc) first diagnosed;
- Clinical diagnosis of breast cancer, or puncture pathology suggests breast cancer;
- After evaluation by experienced clinical physicians, the patient's tumor has the possibility of surgical resection. Specific evaluation indicators include ultrasound assessment of the tumor not surrounding the axillary...
- Accept treatment plans including surgery, radiotherapy, and chemotherapy;
- Volunteer to participate in clinical research and sign an informed consent form;
- Willing to undergo follow-up and complete quality of life (EQ-5D series scale and FACT-B scale) and postoperative psychological status (Anxiety/Depression Self Rating Scale) assessments;
- Patients under 18 years old or over 70 years old;
- Those who have received breast cancer related surgery, radiotherapy or chemotherapy;
- Those who are not expected to receive surgery, radiotherapy or chemotherapy related to breast cancer
- History of other malignant tumors;
- Pregnant or lactating women;
- Accompanying active infection and fever;
- Other serious diseases that may significantly affect clinical trial compliance, such as severe cardiopulmonary dysfunction, liver and kidney dysfunction, poorly controlled diabetes and mental illness.
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.